Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02379858 · ClinicalTrials.gov registry record · NA
Gastrointestinal Tract Recovery in Patients Undergoing Open Ventral Hernia Repair
A NA study, sponsored by Medical College of Wisconsin.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02379858 is a NA study that was terminated before completion, run by Medical College of Wisconsin. The registered enrollment target is 10 participants.
The verdict
NCT02379858, a NA study, was terminated before completion, sponsored by Medical College of Wisconsin.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Alvimopan (Entereg) in ventral hernia surgery patients is associated with accelerated gastrointestinal recovery and reduced length of hospital stay compared to placebo controls.
Interventions
- DRUG Placebo
- DRUG Alvimopan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-07 |
| Est. Completion | 2018-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02379858
The ClinicalTrials.gov registry entry for NCT02379858 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical College of Wisconsin, which has 447 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02379858 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02379858 about?
NCT02379858 is a clinical study titled "Gastrointestinal Tract Recovery in Patients Undergoing Open Ventral Hernia Repair". The purpose of this study is to determine whether Alvimopan (Entereg) in ventral hernia surgery patients is associated with accelerated gastrointestinal recovery and reduced length of hospital stay compared to placebo controls.
What is the current status of trial NCT02379858?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2015-07. Estimated completion is 2018-05-31.
What interventions are being tested in trial NCT02379858?
The interventions under investigation include: Placebo (DRUG), Alvimopan (DRUG).
Who is sponsoring clinical trial NCT02379858?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.